Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07560735 · ClinicalTrials.gov registry record · Phase 4
Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy
A Phase 4 study, sponsored by Toyos Clinic.
- Not yet
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT07560735 is a Phase 4 study that has not yet begun recruiting, run by Toyos Clinic. The registered enrollment target is 30 participants.
The verdict
NCT07560735, a Phase 4 study, has not yet begun recruiting, sponsored by Toyos Clinic.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM
Interventions
- DRUG Lifitegrast Ophthalmic Solution 5.0% (Xiidra)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07560735
The ClinicalTrials.gov registry entry for NCT07560735 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Toyos Clinic, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lifitegrast Ophthalmic Solution 5.0% (Xiidra) is the first listed.
NCT07560735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07560735 about?
NCT07560735 is a clinical study titled "Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy". This is a single center, open label trial to evaluate Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease using In Vivo Confocal Microscopy (IVCM
What is the current status of trial NCT07560735?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2026-04. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07560735?
The interventions under investigation include: Lifitegrast Ophthalmic Solution 5.0% (Xiidra) (DRUG).
Who is sponsoring clinical trial NCT07560735?
This trial is sponsored by Toyos Clinic, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.